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Introduction
Neurons use neuropeptides to initiate and adjust complex behav­
iors and to modulate signaling via classical neurotransmitters 
(Scheller and Axel, 1984; Kupfermann, 1991; Kass et al., 2001; 
Jacob and Kaplan, 2003; Liu et al., 2007; Li and Kim, 2008). 
Neuronal cell somas use the regulated secretory pathway to 
package neuropeptides into dense core vesicles (DCVs). This 
pathway begins in the trans­Golgi, where diverse sorting mech­
anisms cause neuropeptide precursor proteins (proneuropeptides) 
and  their  processing  enzymes  to  coalesce  into  vesicles  that   
bud from the trans­Golgi to form immature DCVs (for reviews   
see Arvan and Castle, 1998; Tooze et al., 2001; Borgonovo   
et al., 2006; Kim et al., 2006). During and after DCV formation, 
prohormone convertases in the vesicle cleave the proneuro­
peptides at dibasic residues, and carboxypeptidase E trims off the 
dibasic residues to produce active neuropeptides (Dikeakos and 
Reudelhuber,  2007). Aggregation  of  proneuropeptides  facili­
tates their sorting from other soluble proteins in the trans­Golgi; 
however,  immature  DCVs  also  contain  soluble  and  trans­
membrane proteins not destined for mature DCVs (for review see 
Tooze et al., 2001). Studies of endocrine cells have revealed 
that, after budding from the trans­Golgi, secretory granules (the 
presumed equivalent of neuronal DCVs) undergo a critical mat­
uration process involving the removal of soluble and transmem­
brane proteins via clathrin­coated vesicles, which then merge 
with early endosomes (for reviews see Arvan and Castle, 1998; 
Tooze et al., 2001). After maturation, neurons use the kinesin 
motor protein KIF1A to transport mature DCVs along micro­
tubules to axons (Jacob and Kaplan, 2003), where they undergo 
regulated secretion.
The complexity of DCV biogenesis and maturation pre­
sents immense challenges to the membrane trafficking machinery. 
Although studies of endocrine cells have revealed the aforemen­
tioned key insights, little is known about how this process occurs 
in neurons and the extent to which endocrine cells and neurons 
use shared or modified trafficking pathways to generate DCVs. 
Rab proteins are a large family of small GTPases that preserve 
compartment identity and ensure directionality and specificity 
during vesicle­mediated transport (Seabra and Wasmeier, 2004; 
Grosshans et al., 2006). Although studies in PC12 cells indicate 
that Rab3 and Rab27 are good candidates for assisting with DCV 
exocytosis (Handley et al., 2007; Graham et al., 2008), Rab 
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signaling, we performed a genetic screen for mutations that 
suppress the slow growing, sickly phenotypes and hyperactive 
behaviors of goa-1 null mutants. Previous studies showed that 
the GOA­1 (Go) pathway exerts its inhibitory effects via the 
EGL­30  (Gq)  pathway  (Hajdu­Cronin  et  al.,  1999;  Miller   
et al., 1999). Many of the goa-1 suppressor mutations mapped 
either directly to Gq or to the Rho­specific GEF (guanine   
nucleotide exchange factor) domain of UNC­73 (Trio), a major 
Gq effector (Fig. S1 A; Lutz et al., 2007; Williams et al., 2007). 
However,  one  class  of  suppressors  included  unc-31  (CAPS) 
mutants (Fig. S1 A), which was previously shown to have im­
paired neuropeptide secretion as the result of a defect in DCV 
exocytosis (Gracheva et al., 2007; Hammarlund et al., 2007; 
Speese et al., 2007; Zhou et al., 2007). To identify other proteins 
that function in DCV trafficking or neuropeptide secretion, we 
focused on the unc-31–like class of goa-1 suppressor mutants, 
which can be distinguished from egl-30 (Gq)–like mutants by 
phenotypic and genetic interactions (Charlie et al., 2006a).
Genetic  mapping  revealed  that  five  of  the  unc-31–like 
goa-1 suppressor mutations disrupted UNC­108 (Rab2), which 
is 88% identical to its human orthologue and is the most highly 
conserved animal Rab (Fig. S1, B and C). A recent study char­
acterized two of these mutations, ce363 and ce365, as recessive, 
reduction­ or loss­of­function mutations resulting in amino   
acid substitutions at conserved residues (Mangahas et al., 2008). 
proteins that function during DCV biogenesis or maturation have 
not been identified.
Caenorhabditis  elegans  is  ideally  suited  for  the  genetic   
investigation  of  neuronal  DCVs  because  mutants  strongly   
impaired for DCV function, though nearly paralyzed, are viable 
(Gracheva et al., 2007; Speese et al., 2007; Hammarlund et al., 
2008). In this study, we used a genetic screen to identify a class 
of C. elegans mutants with phenotypes similar to mutants with 
impaired DCV function. Five of the mutations from this screen 
disrupted UNC­108 (Rab2). Our genetic analysis showed that 
Rab2 functions in the same process or pathway as DCVs but is 
not required for neuropeptide function. The remaining investi­
gation focused on DCV biogenesis and trafficking in Rab2   
null mutants. The results revealed that Rab2 acts during DCV 
maturation in cell somas to prevent the loss of nonneuropeptide   
luminal and membrane cargo from the vesicles.
Results
A genetic suppressor screen implicates 
Rab2 in the function of a G synaptic 
signaling network
In C. elegans, the GOA­1 (Go) pathway is the inhibitory path­
way for regulating synaptic activity during locomotion. To iden­
tify proteins with direct or indirect importance in Go synaptic 
Figure  1.  unc-108  (Rab2)  mutations  suppress   
the  hyperactivity  and  improve  the  growth  of   
goa-1(sa734). (A) Representative photos with geno-
types  indicated.  Images  are  scaled  identically. 
Wild-type length is 1 mm. (B) unc-108 muta-
tions confer sluggish locomotion in (+) and goa-1 
mutant backgrounds. Spontaneous (unstimulated) 
locomotion  rates  of  N2  (wild  type)  compared 
with the indicated genotypes are shown. The last 
three bars are site of action rescue experiments 
in which unc-108 loss-of-function mutants con-
tain transgenes that express the unc-108 cDNA 
from the unc-108 promoter, panneuronally (rab-3 
promoter), or in body wall muscle (myo-3 pro-
moter). Error bars are SEMs of 10 animals each.   
(C) unc-108 single mutants and unc-108 goa-1 
double  mutants  are  sluggish  even  in  response 
to  a  harsh  stimulus.  Locomotion  responses  of 
N2 compared with the indicated genotypes at 
the indicated intervals after a defined mechani-
cal stimulus. Error bars are SEMs of 30 animals 
each. (D) unc-108 and unc-31 mutations improve 
the growth rate of goa-1 null mutants. Error bars 
are  the  SEMs  of  three  populations  of  animals 
plated as first-stage larvae and allowed to grow 
and produce progeny for 96 h at 20°C.883 RAB2 FUNCTIONS IN DENSE CORE VESICLE MATURATION • Edwards et al.
transgenic strain expressing a GFP–UNC­108 fusion in nine 
ventral cord motor neurons revealed a distribution similar to 
that observed by UNC­108 immunostaining. Specifically, most 
neuronal  somas  had  approximately  two  areas  of  concentrated   
UNC­108 along with other nonuniform areas of less­enriched 
The images in Fig. 1 A show the extent to which one of the 
unc-108 mutations transforms a goa-1 null mutant with respect 
to size, body thickness, and posture. The unc-108 mutations re­
duced the hyperactive locomotion of goa-1 mutants to 50–60% 
of wild type (Fig. 1 B). A panel of unc-108 single mutants that 
included the null deletion mutant nu415 (Chun et al., 2008) 
had locomotion rates 25% of wild type (Fig. 1 B). However, 
in response to a defined physical stimulus, the locomotion of   
unc-108 mutants was only 10% of the wild type–stimulated 
rate and, unlike that of wild type, remained unchanged after 
the stimulus (Fig. 1 C). Heterozygous unc-108(ce365)/+ and 
unc-108(ce363)/+  animals  had  locomotion  rates  not  signifi­
cantly different from wild type (Fig. 1 B and not depicted), 
showing  that  these  two  mutations  are  recessive;  however,   
unc-108(ce386) was dominant, and ce386/+ heterozygotes 
had  locomotion  rates  not  significantly  different  from  ce365 
and ce363 homozygotes (Fig. 1 B). Improving the growth of   
goa-1 was the second criterion of the genetic screen. Both dom­
inant and recessive unc-108 mutations improved the population 
growth rate of the goa-1 null approximately six­ to eightfold 
(Fig. 1 D). An unc-31 null mutation improved goa-1’s growth 
rate >20­fold (Fig. 1 D), thus explaining its strong representa­
tion in the suppressor screen along with unc-108 mutants. The 
remainder of this study focuses on the recessive, loss­of­function   
unc-108 alleles, whereas a separate study analyzes the domi­
nant alleles in more detail (see Sumakovic et al. in this issue).
UNC-108 (Rab2) functions in neurons 
to control locomotion and is expressed 
throughout the nervous system
Transgenic site of action experiments showed that driving   
expression of an unc-108 cDNA from either its own promoter 
or a panneuronal promoter rescued the sluggishness of unc-108 
mutants and restored wild­type levels of locomotion, whereas 
driving expression from a body wall muscle promoter had no 
effect (Fig. 1 B). A GFP reporter driven by the rescuing unc-108  
promoter  was  expressed  throughout  the  nervous  system   
(Fig. S2 A). Because we observed expression in all 57 ventral 
cord motor neurons in adult animals (57.3 ± 0.56 SD; n = 3) 
and widespread expression in the head and tail ganglia and body 
neurons, it is likely that UNC­108 is expressed in all neurons. 
Lower levels of the GFP reporter appeared in nonneuronal cells 
as well (Fig. S2, B and C). Immunostaining using an antibody 
raised against recombinant UNC­108 revealed a broad distri­
bution of UNC­108 immunoreactivity in the nervous system   
(Fig. 2 A). Within neuronal cell somas UNC­108 appeared highly   
enriched within or surrounding up to several subcellular struc­
tures roughly 250–500 nm in diameter (Fig. 2 B). Consistent 
with previous studies of Rab2 (Short et al., 2001; Sinka et al., 
2008), these organelles represent the Golgi apparatus because 
fluorescently tagged UNC­108 colocalizes with Golgi markers, 
and Rab2 concentrates in and near the Golgi by immuno­EM 
(Sumakovic et al., 2009). However, UNC­108 immunoreactivity 
also appeared nonuniformly throughout the cytoplasm. Immuno­
staining  and  immunoblotting  comparisons  of  N2  and  the   
unc-108(nu415) null mutant confirmed that the antibody spe­
cifically  recognizes  UNC­108  (Fig.  S2,  D–F).  Imaging  of  a 
Figure 2.  UNC-108 (Rab2) protein is present in the somas and processes 
of neurons but is not concentrated at synapses. (A) The head region of 
an adult animal is coimmunostained with an antibody against UNC-108 
(green) and UNC-17, a cholinergic synaptic vesicle marker (red; Duerr   
et al., 2001). Asterisks mark cell somas expanded in B. (B) Expanded view 
of neuronal cell somas from A showing areas of concentrated UNC-108   
immunoreactivity in neuronal cell somas. Arrows indicate regions of   
especially highly concentrated UNC-108 surrounding subcellular structures. 
The bracketed region indicates lower concentrations of UNC-108 irregu-
larly distributed in the cytoplasm. (C) The vulval region of an adult animal 
coimmunostained with an antibody against UNC-108 (green) and UNC-17   
(red). (D) An N-terminal GFP-tagged version of UNC-108 is highly en-
riched in small subregions (arrows) within DA6 and DB6 neuronal cell 
somas. The genotype of the transgene is ceEx231 [unc-129::GFP–UNC-
108, unc-129::RFP–SNB-1]. Arrowheads point to non–Golgi-related GFP–
UNC-108 fluorescence in the dendrite. (E and F) GFP-tagged UNC-108 is 
largely excluded from synaptic vesicle clusters. Two regions of the dorsal 
cord containing axons of the DA and DB motor neurons. GFP–UNC-108   
is green, and synaptic vesicle clusters marked with RFP–SNB-1 (Sieburth   
et al., 2005) expressed from the same promoter are red.JCB • VOLUME 186 • NUMBER 6 • 2009   884
wild type (Fig. 3, A and C). Similarly, monitoring endogenous 
synaptic activity via the miniature postsynaptic currents (minis) 
that represent the fusion of individual vesicles showed that unc-108 
null mutants have mini frequencies and amplitudes not signifi­
cantly different from wild type (Fig. 3, B, D, and E). These data 
show that neurotransmitter release from small synaptic vesicles 
is unaffected in unc-108 mutants.
unc-108 (Rab2) mutations disrupt a 
function of DCVs during locomotion
unc-108  (Rab2)  mutants  resemble  unc-31  (CAPS)  mutants, 
which have impaired DCV exocytosis (Gracheva et al., 2007; 
Speese  et  al.,  2007;  Zhou  et  al.,  2007;  Hammarlund  et  al., 
2008). The phenotypes of unc-31 null mutants include paralysis 
under most conditions, slow egg­laying rate, a tendency toward 
a straight posture on culture plates, the ability to greatly im­
prove the growth of goa-1 null mutants, and mild resistance to 
the growth­arresting effects of the acetylcholine esterase inhibi­
tor aldicarb (Fig. 1; Charlie et al., 2006a). unc-108 null mutants 
share most of these phenotypes but to a lesser extent when com­
pared with unc-31 null mutants (Fig. 1; unpublished data).
To test whether unc-108 and unc-31 mutations disrupt the 
same pathway or process, we constructed an unc-108; unc-31 
double null mutant. If the unc-108 mutation disrupts locomotion 
by affecting the same process as the unc-31 deletion, it should not 
lower the locomotion rate of the unc-31 null. Consistent with this 
prediction, the locomotion rate of the unc-108; unc-31 double 
null mutant was slightly but significantly higher compared with 
the unc-31 single mutant (Fig. 4 A). This contrasts with results 
using egl-30 (Gq) reduction­of­function mutants, which have 
locomotion rates similar to unc-108 nulls and decrease the 
  locomotion rate of unc-31 nulls by 36­fold (Charlie et al., 2006a). 
Because a major role of UNC­31 in C. elegans is to promote 
DCV exocytosis (Gracheva et al., 2007; Hammarlund et al., 2007; 
UNC­108 (Fig. 2 D). UNC­108 immunoreactivity also co­
incided with the dense network of axons in the nerve ring   
(Fig. 2 A). However, imaging larger synapses at higher reso­
lution  using  both  immunostaining  and  live  animal  imaging   
of GFP–UNC­108 showed that it is largely excluded from the 
synaptic areas of axons (Fig. 2, C, E, and F).
The impaired locomotion of unc-108 
mutants results from functional defects  
in neurons
In quantitative experiments, the synaptic density of cholinergic 
synapses in the ventral nerve cord is unaltered in unc-108   
mutants (Fig. S3 A). In addition, the C. elegans ultraviolet light 
response restored greater than wild­type levels of coordinated 
locomotion to unc-108 mutants after 1 min of illumination 
with blue­violet light (Fig. S3 B and not depicted). This light 
response,  mediated  by  the  LITE­1  ultraviolet  light  receptor, 
largely  bypasses  the  requirement  for  G  synaptic  signaling 
pathways in driving locomotion (Edwards et al., 2008). This 
shows that the impaired locomotion of unc-108 mutants does 
not result from permanent developmental defects or permanent 
damage to neurons, as they develop without UNC­108 (Rab2).
Neurotransmitter release from  
small synaptic vesicles is normal  
in unc-108 mutants
Because unc-108 affects the function of neurons and is strongly   
expressed in all 57 ventral cord motor neurons, we used electro­
physiological  techniques  to  test  whether  unc-108  (Rab2)   
mutants have defects in the exocytosis of small synaptic vesicles 
from ventral cord motor neurons (Richmond et al., 1999).   
Recording  from  unc-108(ce365)  and  the  unc-108(nu415) 
null mutant revealed evoked muscle responses to depolarizing 
nerve cord stimuli that were not significantly different from 
Figure 3.  unc-108 (Rab2) mutants have normal levels of neurotransmitter release from small synaptic vesicles. (A) Representative traces of electrically 
evoked excitatory postsynaptic currents recorded from the body wall muscles of wild type and the indicated unc-108 mutants. (B) Representative traces of 
endogenous miniature postsynaptic currents (minis) recorded from the body wall muscles of wild type and unc-108(ce365). (C) Mean amplitude of electrically 
evoked postsynaptic currents in wild type (WT; n = 21), unc-108(ce365) (n = 13), and unc-108(nu415) (n = 7). Mann-Whitney p-values of ce365 and nu415   
versus N2 are 0.096 and 0.6, respectively. (D and E) Mean frequencies and amplitudes of minis recorded from the body wall muscles of wild type (n = 21),   
unc-108(ce365) (n = 13), and unc-108(nu415) (n = 7). Mann-Whitney p-values of each mutant versus N2 are all ≥0.4. (C–E) Error bars are SEMs.885 RAB2 FUNCTIONS IN DENSE CORE VESICLE MATURATION • Edwards et al.
DCV production, as measured by EM, nor transport to axons is 
impaired in this Rab2 loss­of­function mutant. A related study 
found similar results for other unc-108 mutants, including the 
null mutant nu415 (Sumakovic et al., 2009).
unc-108 (Rab2) mutants have  
strongly reduced levels of soluble  
DCV cargo in their axons
To further investigate which aspect of DCV function unc-108 
mutations disrupt, we analyzed the trafficking of various DCV 
cargo proteins. We first used the NLP­21 proneuropeptide 
tagged at its C terminus with the fluorochrome Venus (Sieburth   
et al., 2007) to follow DCV trafficking in wild­type and unc-108 
Speese et al., 2007; Zhou et al., 2007), this result suggests that the 
functions of Rab2 and DCVs overlap during locomotion.
DCV function in neurons is often equated with neuro­
peptide release. Proneuropeptide processing is required to produce   
functional neuropeptides. Null mutations in EGL­3 (PC2 conver­
tase) block the cleavage of proneuropeptides at dibasic residues 
and eliminate most or all of a known set of neuropeptides, as   
determined by mass spectroscopy of C. elegans lysates (Husson 
et al., 2006); however, it is not clear whether all neuropeptide 
function is abolished in egl-3 null mutants. A null mutation in 
EGL­21 (carboxypeptidase E) disrupts the removal of dibasic 
residues from PC2­cleaved neuropeptides, which is a required 
step for producing functional neuropeptides (Jacob and Kaplan, 
2003; Husson et al., 2007). The locomotion rates of egl-3– and 
egl-21 null single mutants were 25% of wild type and were not 
significantly different from each other, confirming the important 
role of neuropeptides in driving locomotion (Fig. 4 A). This is the 
neuropeptide null phenotype for locomotion because the locomo­
tion rate was not further decreased in egl-21; egl-3 double null 
  mutants (Fig. 4 A). However, the locomotion rate of unc-31 null 
mutants was eightfold lower than egl-3 null mutants and not   
significantly different from unc-31; egl-3 double null mutants 
(Fig. 4 A). This suggests that EGL­3s function completely over­
laps UNC­31’s function but that UNC­31 has one or more other 
functions unrelated to neuropeptide release.
To determine whether egl-3 and unc-108 mutations both 
disrupt the same neuropeptide­releasing function of UNC­31, 
we analyzed unc-108; egl-3 double mutants. The locomotion 
rates of unc-108 and egl-3 single mutants were not significantly 
different from each other (Fig. 4 A). However, the locomotion 
rate of unc-108; egl-3 double null mutants was greatly reduced   
to a level slightly lower than unc-31 null mutants (Fig. 4 A). 
This strong synthetic phenotype suggests that substantial neuro­
peptide function remains in unc-108 null mutants. unc-108; 
egl-3 double null mutants resemble unc-31 null single mutants   
in their overall appearance, posture on culture plates, and re­
sponse (or lack thereof) to harsh stimuli (Fig. 4 B and Videos 
1–5). Together with the other genetic data in Fig. 4, which place 
both EGL­3 (PC2) and UNC­108 (Rab2) in a locomotion func­
tion mediated by DCVs, the similar phenotypes of unc-108; 
egl-3 double mutants and unc-31 single mutants suggest that   
UNC­108 (Rab2) is required for a DCV­mediated locomo­
tion function that is largely nonoverlapping with neuropeptide   
release but that, together with neuropeptide release, accounts for 
the function of DCVs during locomotion.
unc-108 (Rab2) mutants have normal 
numbers of DCVs in their axons
Because the aforementioned genetic analysis implicated UNC­
108 in a process mediated by UNC­31 (CAPS) and because 
UNC­31 mediates DCV exocytosis, we used EM to analyze DCV 
morphology and numbers in unc-108(ce365) mutant axons. The 
DCVs in this unc-108 mutant looked similar to wild­type vesi­
cles, having dense cores and mean diameters not significantly dif­
ferent from wild­type DCVs (Fig. 5, A and B). The number of 
unc-108 mutant DCVs per unit area within synapses was also not 
statistically different from wild type (Fig. 5 B). Thus, neither 
Figure 4.  Genetic analysis suggests that unc-108 (Rab2) mutations dis-
rupt the trafficking or function of DCVs during the locomotion behavior.  
(A) unc-108 (Rab2) and egl-3 (PC2) mutations disrupt different functions of 
UNC-31 (CAPS) in the locomotion behavior. The graph compares the loco-
motion rates of wild type with the indicated mutants. All alleles are null de-
letion mutants. Mann-Whitney p-values between the indicated strains are 
also shown. Error bars are SEMs of 10 animals each. (B) unc-108; egl-3 
double null mutants phenotypically resemble unc-31 null mutants. Repre-
sentative adult animals are shown for each genotype. The body length of 
wild type is 1 mm, and all images have identical magnification. See also 
Videos 1–5.JCB • VOLUME 186 • NUMBER 6 • 2009   886
examined the axonal fluorescence of other Venus­tagged neuro­
peptides in wild­type and mutant backgrounds. Unlike NLP­21, 
the C. elegans neuropeptide FLP­3 is not normally expressed   
in ventral cord motor neurons (Nathoo et al., 2001; Kim and   
Li, 2004), and yet FLP­3–Venus still exhibited reduced axonal 
levels in unc-108 mutants when compared with wild type   
(37% of the wild­type control; Fig. 6 F). We observed a similar   
reduction in axonal levels of ectopically expressed Venus­tagged 
rat atrial natriuretic factor (ANF; ANF­Venus; 33% of the 
unc-108(+) control; Fig. 6 F). The impaired trafficking of these 
DCV cargoes is caused by lack of Rab2 in the neurons express­
ing the cargo because an unc-108 null mutant that expresses the 
unc-108 cDNA only in the cargo­expressing neurons had wild­
type axonal levels of the cargo (Fig. 7, A–C and H).
Blocking neuropeptide processing restores 
greater than wild-type levels of the 
neuropeptide tag in unc-108 mutant axons
The aforementioned data are consistent with at least two pos­
sible DCV­related functions that could be disrupted in unc-108  
mutants: (1) trafficking/retention of neuropeptide cargo in DCVs or 
(2) trafficking/retention of propeptide­derived, nonneuropeptide­
soluble cargo in DCVs. We obtained a further clue by examining 
the delivery of INS­22–Venus to axons in unc-108 mutants. 
INS­22 is one of a group of insulins in C. elegans that lacks PC2 
cleavage sites (Pierce et al., 2001), whereas NLP­21, FLP­3, and 
ANF all contain multiple PC2 cleavage sites. When we compared   
INS­22–Venus in unc-108(+) and mutant backgrounds, the 
unc-108 mutation only reduced its axonal fluorescence to 74% 
of wild type (Fig. 6, D–F), suggesting that neuropeptide processing   
affects trafficking of the cleaved Venus tag in unc-108 mutants. To   
further test this, we crossed the NLP­21–Venus transgene into   
egl-3 null mutants, which cannot cleave proneuropeptides into their 
constituent  peptides.  Whereas  axonal  NLP­21–Venus  levels 
mutant live animals. This genomically integrated transgene 
expresses the tagged propeptide in a set of nine DA/DB ven­
tral cord motor neurons, which allows quantitative imaging of 
defined axonal and cell soma regions (Fig. S4). Because it is 
widely accepted that regulated secretory proteins aggregate in 
the acidic lumen of DCVs (for review see Tooze et al., 2001), 
we hypothesize that the Venus tag on the propeptide is in an 
aggregated state in the DCV before peptide processing. After   
peptide  processing,  we  hypothesize  that  the  NLP­21  neuro­
peptides remain aggregated, but the Venus tag, now containing 
only one amino acid from the original propeptide (Nathoo et al., 
2001), becomes soluble (Fig. S4). Hereafter, we refer to Venus 
liberated from the propeptide by peptide processing as soluble 
Venus or soluble DCV cargo. However, although a peptide   
processing–induced change in Venus’s solubility state is con­
sistent with forthcoming results in this study, such a change   
remains to be demonstrated at a biophysical level.
A previous study found that a substantial amount of the 
soluble Venus tag from the NLP­21 propeptide remains within 
DCVs as they move to axons and is released by an UNC­31–
dependent process (Sieburth et al., 2007). When we imaged 
NLP­21–Venus in the dorsal axons of wild­type animals, we 
observed concentrated punctal fluorescence along the axons, as 
previously reported (Fig. 6 A; Sieburth et al., 2007). However, 
when we crossed this transgenic array into unc-108 mutants, 
the NLP­21–Venus levels, although still punctal in nature, 
were strongly reduced in intensity (Fig. 6, B and C). The inte­
grated fluorescence per micrometer was reduced to 25–30% 
of wild­type levels in a group of three unc-108 mutants that   
included the unc-108(nu415) null deletion mutant (Fig. 6 F). 
In contrast, double mutants lacking both Rab proteins involved 
in DCV exocytosis (Rab3 and Rab27) had higher axonal levels 
of NLP­21–Venus (126 ± 6.6% of wild type for aex-6(sa24);   
rab-3(js49) double mutants; n = 14 animals each). We also   
Figure  5.  unc-108  (Rab2)  mutants  have 
normal  numbers  of  DCVs  in  their  axons.   
(A)  Representative  high  pressure  freezing 
EM images of wild-type and unc-108(ce365) 
mutant  axons.  Open  arrowheads  indicate 
DCVs; closed arrowheads indicate presynap-
tic densities. (B) Summary of DCV statistics in 
wild-type and unc-108(ce365) mutant axons. 
Data are means ± SEMs from the indicated 
sample sizes. The difference in DCV number 
between wild type and the unc-108 mutant is 
not statistically significant (P = 0.11; Mann-
Whitney test).887 RAB2 FUNCTIONS IN DENSE CORE VESICLE MATURATION • Edwards et al.
To determine whether the soluble Venus cargo is lost by a   
PI(3)P­dependent process in unc-108 null mutants, we coexpressed 
NLP­21–Venus and 2XFYVE­RFP, which specifically recog­
nizes PI(3)P and marks early phagosomes and early endosomes 
in C. elegans (Roggo et al., 2002; Yu et al., 2006). 2XFYVE   
expression has previously been shown to block PI(3)P­dependent 
processes in DCVs (Meunier et al., 2005). Under these condi­
tions of excess 2XFYVE, we observed no significant difference 
between wild type and unc-108 null mutants in the levels or   
appearance of NLP­21–Venus in axons (Fig. 7, F–H). These data 
suggest that the reduced axonal levels of the soluble Venus tag 
in unc-108 mutants result from its loss by a PI(3)P­dependent 
membrane trafficking process. Experiments using a dominant­
active RAB­5 transgene to block membrane trafficking through 
early endosomes in unc-108 mutants produced similar results 
(Sumakovic et al., 2009).
A trafficking event in neuronal cell somas 
reduces soluble DCV cargo in unc-108 
mutant axons
Because DCV biogenesis and maturation occur in cell somas, we 
next examined NLP­21–Venus levels in the cell somas of wild 
in unc-108 null single mutants were only 32% of wild type, this   
level increased 4.3­fold in unc-108; egl-3 double null mutants, 
to 1.4­fold greater than wild type (Fig. 7, A–E and H). egl-3 single 
mutants also had twice as much axonal NLP­21–Venus as wild type   
(Fig. 7, D and H), suggesting that, in wild type, about half of the 
soluble Venus cargo is removed from DCVs after peptide process­
ing or that DCVs only partially complete their peptide processing 
before entering axons and escaping the trafficking pathways that 
remove soluble proteins. The major conclusion from this series of 
experiments is that neurons lacking Rab2 lose about two thirds of 
their soluble Venus cargo after proneuropeptide processing.
Interfering with PI(3)P function  
restores normal levels of soluble DCV 
cargo in unc-108 mutant axons
In pancreatic  cells, clathrin­coated vesicles bud from immature 
DCVs and carry soluble and transmembrane cargo not destined 
for mature DCVs to early endosomes, from which their com­
ponents are either secreted or sent to lysosomes (Turner and   
Arvan, 2000). PI(3)P is essential for the trafficking of mem­
branes  through  early  endosomes  (Di  Paolo  and  De  Camilli, 
2006; Grosshans et al., 2006; Lindmo and Stenmark, 2006).   
Figure  6.  unc-108  (Rab2)  mutants  have 
strongly  reduced  levels  of  PC2-processed   
Venus cargo in their axons. (A–E) Representa-
tive images of Venus-tagged neuropeptides in 
DA/DB motor neuron axons in animals with 
the  indicated  genetic  backgrounds.  Strains 
containing  the  same  transgenic  array  are 
scaled identically for brightness after adjust-
ing  for  differences  in  light  source  power.   
NLP-21–Venus  and  INS-22–Venus  are  ex-
pressed  from  the  integrated  transgenic  ar-
rays  nuIs183  and  nuIs195,  respectively. 
(A–C) UNC-108 is required for normal lev-
els and density of the Venus cargo in axons.   
(D  and  E)  A  peptide  tag  not  cleaved  from 
the  proneuropeptide  by  PC2  convertase  is 
transported  to  axons  in  unc-108  mutants.   
(F)  Quantification  of  Venus  cargo  fluores-
cence in the dorsal axons of unc-108 mutants. 
The graph shows the total integrated fluores-
cence per micrometer of dorsal axon length, 
expressed as a percentage of the wild-type 
control, of various tagged neuropeptides in 
the indicated mutant backgrounds. Data are 
means and SEMs from images acquired from   
6 to 16 individual animals each. NLP-21–Venus, 
FLP-3–Venus, ANF-Venus, and INS-22–Venus 
were  expressed  from  the  integrated  trans-
genic arrays nuIs183 (or ceIs56 for nu415), 
ceIs61,  ceIs62,  and  nuIs195,  respectively. 
P-values are from a Mann-Whitney test and 
unpaired t test with Welch correction.JCB • VOLUME 186 • NUMBER 6 • 2009   888
wild type, only slightly higher than the level in egl-3 single 
mutants (Fig. 8, C, D, and G). The trafficking event also depends 
on PI(3)P because coexpressing 2XFYVE­RFP eliminated the 
difference between wild type and unc-108 null mutants with 
respect to Venus levels in the cell somas (Fig. 8, E–G).
Transmembrane cargo is lost from 
maturing DCVs in the absence of Rab2
The clathrin­coated vesicles that carry soluble proteins from 
immature DCVs to the endosomal system are also thought to 
carry membrane proteins not destined for mature DCVs (Turner 
and Arvan, 2000; for review see Tooze et al., 2001). To investi­
gate the extent to which aberrant trafficking in unc-108 mutants 
type and unc-108 mutants. In these experiments, we imaged a 
pair of identified neurons, DA6 and DB6, which are adjacent in 
the ventral nerve cord (Fig. S4). Each neuron sends a dendrite 
in the direction of the other neuron, so the images included the 
dendrites as well. NLP­21–Venus levels in unc-108 null mutant 
cell somas were reduced to 57% of the level in wild­type somas   
(Fig. 8, A, B, and G). Thus, the reduced axonal level of the 
NLP­21–Venus tag in unc-108 null mutants results from a traf­
ficking event in cell somas that ultimately results in its degreda­
tion or secretion. The trafficking event that removes the Venus tag 
in unc-108 mutant somas depends on peptide processing because 
blocking peptide processing with the egl-3 null mutation restored   
NLP­21–Venus levels in unc-108 mutant somas to 160% of 
Figure 7.  Blocking neuropeptide processing 
or PI(3)P restores normal levels of the Venus 
cargo in unc-108 mutant axons. (A–G) Repre-
sentative images of NLP-21–Venus in DA/DB 
motor neuron axons in animals with the indi-
cated genetic backgrounds. Strains containing 
the same transgenic array are scaled identi-
cally for brightness after adjusting for differ-
ences  in  light  source  power.  NLP-21–Venus 
is  expressed  from  the  integrated  transgenic 
array ceIs56 in A–E and ceIs57 in F and G.   
(A and B) UNC-108 is required for normal lev-
els and density of the Venus cargo in axons. 
(C) UNC-108 acts cell-autonomously in motor 
neurons  during  DCV  cargo  trafficking.  This 
strain is identical to that in B except that it con-
tains the ceEx282 transgene, which expresses 
the unc-108 cDNA in the same motor neurons 
as NLP-21–Venus. (D and E) Blocking peptide 
processing  with  an  egl-3  (PC2  convertase) 
null  mutation  restores  greater  than  wild-type 
levels of the neuropeptide tag in the axons of 
wild type and unc-108 null mutants. (F and G) 
Blocking PI(3)P function with excess 2XFYVE 
restores normal levels of the neuropeptide tag   
in the axons of wild type and unc-108 null   
mutants. (H) Quantification of Venus levels in 
the dorsal axons of unc-108 mutants. The graph 
shows the total integrated fluorescence per   
micrometer of dorsal axon length, expressed   
as arbitrary fluorescence units (a.f.u.). Data are 
means and SEMs from images acquired from 
11  to  14  individual  animals  each.  NLP-21– 
Venus  was  expressed  from  the  ceIs56  inte-
grated array for the first five bars and from the 
ceIs57 integrated array for the last two bars. 
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specific to DCVs in vertebrate neurons (Solimena et al., 1996), 
and is a marker for DCVs in C. elegans (Cai et al., 2004; Zhou 
et  al.,  2007). An  integrated  IDA­1–GFP  transgene  showed   
a  punctate  localization  in  wild­type  axons  that  resembled   
affects the membrane protein composition of mature DCVs,   
we compared the trafficking of GFP­tagged IDA­1 in wild type   
and unc-108 null mutants. IDA­1 is the C. elegans orthologue   
of IA­2 (insulinoma­associated protein 2), a membrane protein 
Figure 8.  Blocking neuropeptide processing or   
PI(3)P restores normal levels of the Venus cargo   
in  unc-108  mutant  cell  somas.  (A–F)  Rep-
resentative  images  of  NLP-21–Venus  in 
DA6/DB6  motor  neuron  cell  somas  in  ani-
mals with the indicated genetic backgrounds. 
Strains  containing  the  same  transgenic  ar-
ray  are  scaled  identically  for  brightness   
after adjusting for differences in light source 
power. NLP-21–Venus is expressed from the 
integrated  transgenic  array  ceIs56  in  A–D   
and ceIs57 in E and F. DA6 and DB6 neu-
rons  show  variable  spacing.  The  process 
between  the  somas  is  a  dendrite,  not  an 
axon. (A and B) UNC-108 is required for nor-
mal levels of the Venus cargo in cell somas.   
(C and D) Blocking peptide processing with 
an  egl-3  (PC2  convertase)  null  mutation  re-
stores near normal levels of the Venus cargo in   
the cell somas of unc-108 null mutants. (E and F) 
Blocking PI(3)P function with excess 2XFYVE 
restores normal levels of the Venus cargo in 
the cell somas of wild type and unc-108 null 
mutants.  (G)  Quantification  of  Venus  cargo 
levels in the cell somas of unc-108 mutants. 
The graph shows the total integrated fluores-
cence per square micrometer of cell soma and 
dendrite  area,  expressed  as  arbitrary  fluor-
escence  units  (a.f.u.).  Data  are  means  and 
SEMs from 10 to 15 individual animals each.   
P-values are from a Mann-Whitney test.JCB • VOLUME 186 • NUMBER 6 • 2009   890
endosomal system by a PI(3)P­dependent membrane trafficking 
process, from which it is likely secreted or sent to lysosomes, 
as indicated by decreased levels of the Venus tag in unc-108 
mutant  somas.  The  ida-1  transgene  produces  IDA­1  tagged 
with GFP on its cytoplasmic side. Because this GFP tag can­
not be secreted or easily broken down by lysosomes, the low 
axonal levels of IDA­1–GFP in unc-108 mutants should be as­
sociated with higher levels in the cell somas, which is the case.   
NLP­21–Venus expressed in the same neurons (Fig. 9 A).   
However, crossing the transgene into the unc-108 null mutant   
reduced the axonal levels of IDA­1–GFP to 33% of wild type 
(Fig. 9, B and C). This level is not significantly different from 
the extent to which the soluble NLP­21–derived Venus tag is   
reduced in unc-108 mutant axons (32%; Fig. 7 G).
Data  presented  in  the  previous  two  sections  suggested   
that the soluble NLP­21–derived Venus tag is trafficked to the 
Figure  9.  Transmembrane  cargo  is  lost 
from maturing DCVs in the absence of Rab2.  
(A and B) Representative images of IDA-1–GFP 
in DA/DB motor neuron axons in wild type   
(A) and unc-108(nu415) (B). Images are scaled 
identically  for  brightness  after  adjusting  for 
differences in light source power. IDA-1–GFP 
is  expressed  from  the  integrated  transgenic   
array ceIs72. (C) Quantification of IDA-1–GFP 
fluorescence in the dorsal axons of wild type 
and the unc-108 mutant. The graph shows the 
total  integrated  fluorescence  per  micrometer 
(arbitrary fluorescence units [a.f.u.]) of dorsal 
axon  length  in  the  indicated  backgrounds.   
(D and E) Representative images of IDA-1–GFP 
in DA6/DB6 motor neuron cell somas in wild 
type  (D)  and  unc-108(nu415)  (E).  Images 
are scaled identically for brightness after ad-
justing for differences in light source power.   
(F) Quantification of IDA-1–GFP fluorescence 
in the DA6/DB6 cell somas of wild type and 
the unc-108 mutant. The graph shows the total 
integrated fluorescence per square micrometer 
(arbitrary fluorescence units) of cell soma and 
dendrite area in the indicated backgrounds. 
(C and F) Data are means and SEMs from 14 
animals for each strain. The p-values are from 
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to membrane trafficking events. In addition to normal levels 
of aggregated neuropeptides, unc-108 mutant vesicles contain 
all of the necessary components for exocytosis, as indicated by 
coelomocyte uptake assays (Sumakovic et al., 2009), the lack of 
DCV accumulation by EM, and by our finding that knocking out 
neuropeptide function strongly decreases the locomotion of an   
unc-108 null mutant (i.e., showing that neuropeptides continue 
to function in unc-108 mutants). However, our genetic analysis 
shows that DCVs lacking Rab2 cannot carry out a critical func­
tion unrelated to neuropeptide release. Catecholamines can also 
be packaged into DCVs and, being soluble molecules, would be 
vulnerable to loss in unc-108 mutants; however, mutants lack­
ing catecholamines have normal locomotion rates by the assays 
in this study (unpublished data), so catecholamine release is   
unlikely to be the missing function. Other possibilities include 
soluble  neurotrophins  such  as  BDNF  (brain­derived  neuro­
trophic factor) or NT­3–like proteins, which are known to be 
released by DCVs (Michael et al., 1997; Mowla et al., 1999; 
Sadakata et al., 2007), growth factors such as TGF­ that might 
be secreted by the regulated secretory pathway (Specht et al., 
2003), one or more membrane proteins that might use DCVs 
for transport to synapses such as a G protein–coupled receptor 
(Guan et al., 2005), or even a membrane domain with a unique   
phospholipid or lipid–protein composition.
Rab2’s specific function during  
DCV maturation
Previous studies suggested that Rab2 functions in ER to Golgi 
trafficking based on overexpression of putative dominant­negative 
Rab2 proteins in cell lines using Golgi­mediated glycosylation 
of vesicular stomatitis virus G protein as an assay (Tisdale et al., 
1992; Tisdale and Balch, 1996). However, a recent study found 
normal Golgi­mediated glycosylation and anterograde transport 
of proteins in C. elegans neurons lacking Rab2 (Chun et al., 
2008).  Rab2’s  strong  enrichment  in  and  around  the  Golgi   
(Sumakovic et al., 2009) and its direct binding to Golgins and 
other Golgi­localized proteins (Short et al., 2001; Sinka et al., 
2008) seem to suggest a role for Rab2 in a Golgi­specific func­
tion. However, light­level immunostaining (this study) and   
immuno­EM (Sumakovic et al., 2009) showed that Rab2 is also 
associated to a lesser degree with other compartments around 
the Golgi, and an earlier study found Rab2 transiently enriched 
IDA­1–GFP in unc-108 mutant somas was 200% of its level 
in  wild­type  somas  (Fig.  9,  D–F).  This  does  not  precisely 
compensate for the 300% decrease in unc-108 mutant axons, 
which suggests that the cell somas degrade some of the excess   
IDA­1–GFP or at least its GFP tag. In summary, the IDA­1–
GFP data suggest that the same process that depletes the soluble 
Venus tag from the DCV lumen in cell somas also strips most of 
the transmembrane cargo IDA­1 from DCVs.
Normal levels of processed neuropeptides 
in unc-108 mutant axons
Our finding that propeptide processing makes unc-108 mutant 
DCVs vulnerable to losing the soluble Venus tag raises the pos­
sibility that processed neuropeptides might also be lost from the 
mutant’s vesicles. If this is true, animals lacking Rab2 should 
have reduced levels of native, processed neuropeptides in their 
axons. To test this, we immunostained the mutants with an anti­
body that recognizes processed FMRFamide neuropeptides in 
C. elegans (Schinkmann and Li, 1992). The levels of native 
FMRFamide neuropeptides in the dorsal axons of wild type and 
unc-108 null mutants were not significantly different (Fig. 10). 
This is consistent with the genetic analysis showing that sub­
stantial neuropeptide function remains in unc-108 null mutants 
and the EM analysis showing normal numbers of DCVs in   
dorsal axons. The FMRFamide immunostaining also suggests 
that propeptide processing occurs normally in unc-108 mutant 
DCVs because in a previous study, disruption of peptide pro­
cessing strongly affected the ability of this antibody to recog­
nize its substrates in axons (Jacob and Kaplan, 2003).
Discussion
Functional state of DCVs produced 
without Rab2
Although the DCVs emerging from unc-108 mutant somas lack 
two thirds of their transmembrane and soluble cargoes, the EM 
and FMRFamide­related peptide immunostaining data suggest 
that they contain normal aggregated neuropeptide cores. Fur­
thermore, blocking peptide processing or attaching the tag to a 
peptide that lacks processing sites (thus presumably keeping the 
tag aggregated) prevents its loss. This is not surprising given the 
aggregated nature of the core, which would not be accessible 
Figure 10.  An unc-108 (Rab2) null mutant has normal levels of processed FMRFamide neuropeptides in its dorsal nerve cord. Identically scaled representa-
tive images of native FMRFamide neuropeptide and GABAergic synapse immunostaining in the dorsal axons of wild type (top) and the unc-108(nu415) 
null mutant (bottom). The text in each image states the means and SEMs of the FMRFamide/GABAergic synapse fluorescence intensity ratio from 14 to 15 
animals per strain. P = 0.98 (Mann-Whitney test). See Materials and methods for further details.JCB • VOLUME 186 • NUMBER 6 • 2009   892
would accumulate at high levels in the endosomal system (Chun 
et al., 2008), coelomocytes, having abnormally high endocytic 
activity, would show impaired trafficking of fluid phase markers 
(Chun et al., 2008; Mangahas et al., 2008), and maturing DCVs 
would be vulnerable to assault by early endosomes and loss of 
their soluble and transmembrane cargo (Sumakovic et al., 2009; 
this study).
Materials and methods
Worm culture and strains
Worm culture and manipulation essentially followed previously described 
methods (Brenner, 1974; Stiernagle, 2006), with modifications as de-
scribed previously (Edwards et al., 2008). In brief, culture media was 
modified Nematode growth medium, containing no added Ca or Mg, and 
consisted of the following (per liter): 2 g NaCl, 3.1 g peptone, 3.0 g 
KH2PO4, 0.5 g K2HPO4, and 20 g A-7002 agar (Sigma-Aldrich). After   
autoclaving and cooling to 55°C, the following was added (per liter): 1.6 ml 
of 5 mg/ml cholesterol in ethanol, 1.0 ml of 100 mg/ml Streptomycin in 
double distilled H2O, and 1.25 ml of 10 mg/ml Mycostatin suspension in 
ethanol. Wild-type worms were the N2 strain. See Table S1 for the com-
plete genotypes of all other strains used in this study.
Forward genetic screens
We mutagenized L4-stage goa-1 mutants with 1 mM ENU (N-ethyl-N-nitro-
sourea) dissolved in ethanol (De Stasio and Dorman, 2001) or 46 mM EMS 
(ethyl methanesulfonate) in M9 (Sulston and Hodgkin, 1988). We produced 
synchronous F2 grandprogeny of the mutagenized animals and plated these 
animals as young larvae on 24-well culture plates using a repeat pipetter to 
plate 100 animals in each well for a total of 50,000 F2 animals (ENU) in 
2 weekly cycles or 600,000 F2 animals in 10 weekly cycles (EMS). We 
screened both the F2 and F3 generations on these plates but had the most 
success in screening the F3 generation, which involved growing the cultures 
2 d at RT and 4 d at 20°C after plating. We screened the wells for mutants 
with improved growth and reduced hyperactive behaviors, including loco-
motion and egg laying.
Mapping, identification, and outcrossing of suppressor mutations
Suppressor mutants resembling egl-30, unc-31, unc-2, or unc-73 mutants 
were complement tested with Dpy-marked versions of these mutants be-
fore or after outcrossing from the goa-1 allele. To map the unc-108 alleles 
ce363 and ce365, we first separated the mutations from goa-1(sa734) by 
crossing N2 males to the suppressed strain and isolating putative suppres-
sor single mutants in the F2 generation based on their predicted sluggish 
phenotype. Animals that were both homozygous for the mutation and did 
not segregate goa-1(sa734) were kept as 1× outcrossed strain stocks. We 
then produced 5× outcrossed versions of each mutant in goa-1(+) and 
goa-1(sa734) backgrounds. During outcrossing, we found tight linkage to 
the goa-1 locus on chromosome I. We then mapped the mutations relative 
to single nucleotide polymorphisms (SNPs) to a 416-kb region centered 
around 2.0 cM on chromosome I (Fig. S1 B) using a previously described 
method (Schade et al., 2005). We used the following SNP markers to map 
the mutations within this region (marker names are followed by genome 
location, base pair change, and, if relevant, the restriction enzyme that can 
identify the SNP): ceP62 [I:3,573,375 (C/T BanII)], ceP63 [I:4,132,726 
(T/A  ClaI)],  ceP64  [I:4,663,859  (C/G  HinfI)],  ceP194  [3,806,411   
(T/A)], and ceP195 [I: 3,989,632 (G/A)]. We then used candidate gene 
sequencing of the genomic DNA of each mutant and/or transformation 
rescue experiments to confirm that all five mutants were unc-108 alleles.
Plasmids
Table S2 lists all of the plasmids used in this study along with their construc-
tion details. In all constructs involving the cloning of PCR fragments, we   
sequenced  the  inserts  and  used  clones  containing  no  mutations  in  the   
fragment of interest to establish the final plasmid stock.
Transgene production
We produced transgenic strains bearing extrachromosomal arrays by the 
method of Mello et al. (1991). For all rescue experiments, the original host 
was unc-108(ce365) or unc-108(nu415); ceIs56, as indicated. For all other 
experiments, N2 was the original host. We used pBluescript carrier DNA to 
bring the final concentration of DNA in each injection mixture to 175 ng/µl 
on  newly  formed  phagosomes,  which  are  essentially  early   
endosomes (Mangahas et al., 2008). Because the Golgi is a   
major hub for membrane trafficking to and from early endo­
somes, we favor the idea that Golgins serve to maintain a pool 
of concentrated Rab2 near its site of action, which, for this func­
tion of Rab2, would be immature DCVs near the Golgi and the 
tubules of early endosomes.
Our study highlights the importance of Rab2 in the DCV 
maturation process that produces fully functional DCVs in neu­
rons. Much of what we know of DCV maturation comes from 
studies using nonneuronal cell lines, which may lack the require­
ment for one or more nonneuropeptide­related DCV functions 
that are critical for neurons (for reviews see Arvan and Castle, 
1998; Tooze et al., 2001; Borgonovo et al., 2006; Kim et al., 
2006). In endocrine cells, DCV maturation begins with the 
synaptotagmin  IV–dependent  homotypic  fusion  of  immature 
DCVs (Ahras et al., 2006; for review see Tooze et al., 2001). 
However, the precise remodeling interactions that occur between 
homotypically fused vesicles and early endosomes and how these 
interactions affect mean DCV size, which we found to be un­
changed in mutants lacking Rab2, are unknown. Early endo­
somes are dynamic and often tubulovesicular (Maxfield and 
McGraw, 2004; Lindmo and Stenmark, 2006). Although matura­
tion uses clathrin­based membrane removal mechanisms, direct 
interactions between homotypically fused immature DCVs and 
the tubules of early endosomes have not been ruled out.
The  data  presented  in  this  study  seem  to  support  two   
hypotheses for Rab2’s specific function during DCV maturation. 
First, Rab2 may speed up a rate­limiting step of the regulated 
secretory pathway such that DCVs are minimally exposed to 
early endosomes in the cell soma. If this is the case, Rab2’s 
function in DCV maturation may be similar to its function dur­
ing phagosome maturation, where it increases the rate of phago­
some maturation but is not absolutely required for it (Lu et al., 
2008; Mangahas et al., 2008). In a second, equally tenable,   
hypothesis, Rab2 may inhibit the immature DCV to early endo­
some trafficking pathway by, for example, limiting the mass or 
lifetime of early endosomes. Consistent with this possibility, a 
recent study found an increase in tubulovesicular structures 
that correspond to early and recycling endosomes in unc-108 
mutant neuronal cell somas (Chun et al., 2008). In a more   
specific variation of this hypothesis, Rab2 may directly or indi­
rectly regulate the conversion of PI(3)P to other phosphoinositides, 
much as Rab5 recruits and regulates PI(3) kinase, the enzyme 
that makes PI(3)P (Di Paolo and De Camilli, 2006; Lindmo and 
Stenmark, 2006). In this scenario, the absence of Rab2 would 
lengthen both the lifetime and mass of early endosome tubules, 
which  derive  their  identity  from  PI(3)P  (Di  Paolo  and  De   
Camilli, 2006; Lindmo and Stenmark, 2006), thus resulting in 
excessive interactions between DCVs and early endosomes. 
Supporting this hypothesis is the finding that unc-108 mutant 
phagosomes show a long delay as they mature through the early 
endosome compartment, and this delay correlates with the per­
sistence of PI(3)P (Mangahas et al., 2008). Thus, as early and 
recycling endosomes increase in mass or lifetime in animals 
lacking Rab2, phagosome maturation would slow (Lu et al.,   
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C.  Li  (City  College  of  New  York,  New  York,  NY).  We  used  the  anti– 
UNC-47 and -FMRFamide serums at 1:12,000 and 1:2,000, respectively, 
after fixing worms for 16 h at 4°C in 4% paraformaldehyde (Schinkmann 
and Li, 1992). We performed all other steps of freeze-cracking and immuno-
staining whole mounts of adult animals as previously described (Charlie 
et al., 2006a,b).
We produced lysates for immunoblotting by producing and isolat-
ing 450,000 eggs per strain. After hatching 18 h at RT on culture plates 
lacking food, we collected synchronous L1 larvae and counted them by 
titering. We produced a 300-µl suspension of 1,500 larvae/µl, added an 
equal volume of 5× SDS-PAGE sample buffer, and immediately froze the 
suspension in liquid nitrogen. After thawing the suspension in a boiling   
water bath for 3 min, we passed it three times forcefully through a 26-gauge 
needle using a tuberculin syringe to produce a lysate. After spinning the 
lysate for 5 min at 14,000 g, we resolved the equivalent of 2,625 L1 lysed 
larvae of each strain on an 11% SDS-PAGE gel, blotted to nitrocellulose, 
stained with Ponceau S to visualize molecular mass markers, blocked over-
night at 4°C with 3% nonfat dry milk in TBS, and probed the blot with the 
affinity-purified unc-108 antibody diluted 1:1,000 for 1 h at RT in TBST 
(TBS with Tween 20) with 3% nonfat dry milk. Blots were subsequently   
washed and processed according to the manufacturer’s instructions for 
SuperSignal West Pico (Thermo Fisher Scientific) and exposed to film   
(BioMax Light; Kodak) to visualize immunoreactive bands.
EM
High pressure freezing and freeze substitution were performed as previ-
ously described (Rostaing et al., 2004). A 100-µm-deep aluminum platelet 
(Microscopy Services) was filled with Escherichia coli OP-50 suspension. 
Approximately 20 young adult worms were transferred into the chamber 
and immediately frozen using an HPM 10 (BAL-TEC). Freeze substitution 
was performed in an electron microscope (AFS or AFS2; Leica). For mor-
phological investigations, incubations were at 90°C for 100 h in 0.1% 
tannic acid and for 7 h in 2% OsO4 and at 20°C for 16 h in 2% OsO4, 
followed by embedding in Epon at RT (all solutions wt/vol in dry acetone). 
DCVs were quantified from the central profile of each synapse (i.e., from a 
single EM section for each synapse), and the numbers were normalized to 
0.2-µm
2 synaptic profile areas.
Imaging and image analysis
We imaged whole-mounted immunostained adults for UNC-108 and UNC-
17 as previously described (Charlie et al., 2006b) using donkey anti–goat 
and donkey anti–mouse Cy2- and Alexa Fluor 555–labeled secondary 
antibodies, respectively. We imaged whole-mounted immunostained adults 
for FMRFamide peptides and UNC-47 GABAergic synaptic vesicle clusters 
using donkey anti–rabbit and donkey anti–goat Alexa Fluor 555– and 
Cy2-labeled secondary antibodies, respectively. For quantitative immuno-
staining, we used the equipment and quantitative imaging techniques   
described below for live animal imaging. We inferred that dorsal cord   
immunoreactivity derived from the RID motor neuron axon based on a pre-
vious study (Schinkmann and Li, 1992).
We produced live adults for imaging fluorescent-tagged proteins by 
plating 10–14 L2-stage larvae on each of five locomotion plates (plates 
were spread with 100 µl of OP-50 bacterial culture and grown for 16 h, 
lid side up, at 37°C before storing at 4°C) and growing 6 d at 20°C to 
produce next-generation adult progeny. Approximately 45 young adults 
were selected and transferred to an unseeded plate, from which we loaded 
them into a 15-µl drop of 30 mg/ml BDM (2,3-Butanedione monoxime; 
Sigma-Aldrich; Sieburth et al., 2005) in M9 buffer on a coverslip. After 
adding another 15 µl of 30 mg/ml BDM, we covered the coverslip   
and a piece of water-moistened KimWipe with a Petri dish lid. After   
10 min, we removed 27 µl of the solution using a P20 microinjection tip 
(Eppendorf), leaving the worms behind in a small amount of anesthetic. 
We mounted the coverslip with the worms on a 2% agarose pad (Sulston 
and  Hodgkin,  1988),  with  the  agarose  dissolved  in  M9  buffer.  After 
straightening the coverslip and nudging 1 mm to help with dorsal/ventral 
orientation, we sealed each corner with a dab of clear nail polish and   
imaged animals over the next 35–55 min. In general, two such slides were 
necessary to obtain images from 14 animals in the correct orientation.
We  collected  images  at  22°C  using  an  inverted  microscope 
(Eclipse TE2000-E; Nikon) equipped with a CFI Apochromat total internal 
reflection fluorescence 100× NA 1.49 objective (with no additional tube 
lens or optivar magnification; Nikon), a motorized linear-encoded high 
resolution z drive (Nikon), a SmartShutter ultrafast shutter (Sutter Instru-
ment Co.) with a Lambda SC controller and a foot pedal switch (Sutter   
Instrument Co.), and a motorized filter turret containing GFP, CFP, YFP, and 
and integrated arrays into the genome as previously described (Reynolds   
et al., 2005). Table S3 lists all of the transgenic arrays used in this study, their 
plasmid contents, and the injection concentration of each plasmid.
Live animal assays
The live animal assays have been described in detail in recent studies and 
were  performed  in  this  study  without  modification:  locomotion  assays 
(Miller et al., 1999; Reynolds et al., 2005), stimulated locomotion assays 
(Charlie et al., 2006b), population growth rate assays (Williams et al., 
2007),  and  light–dark  locomotion  assays  (Edwards  et  al.,  2008).  We   
captured and converted videos of worms on culture plates as previously   
described (Schade et al., 2005).
Double mutants
We constructed double mutants using the standard method of crossing 
heterozygous males of mutant A with homozygous hermaphrodites of mutant 
B and cloning virgin F1 cross progeny. From plates segregating mutant A 
in their F2 progeny, we cloned mutant A and/or B animals and looked for 
segregation of the double mutant in the next generation. In some cases, we 
used PCR to identify plates carrying or homozygous for various deletion   
alleles. For doubles with transgenes, we cloned candidate doubles directly 
from the F2 progeny and chose one line homozygous for the fluorescent 
and behavioral phenotypes in the next generation. For all doubles not   
involving transgenic arrays, we confirmed the homozygosity of both alleles 
by PCR and/or sequencing genomic DNA from the final strain.
Electrophysiology
Electrophysiological  methods  were  performed  as  previously  described 
(Richmond et al., 1999) with the following modifications: ventral body wall 
muscle cells were recorded in the whole cell voltage-clamp mode (holding 
potential of 60 mV) using an EPC-10 patch-clamp amplifier (HEKA) and 
digitized at 1 kHz. The extracellular 340-mosM solution, pH 7.4, con-
sisted of 150 mM NaCl, 5 mM KCl, 5 mM CaCl2, 4 mM MgCl2, 10 mM 
glucose, 5 mM sucrose, and 15 mM Hepes. The patch pipette was filled 
with an 315-mosM solution, pH 7.2, of 120 mM KCl, 20 mM KOH,   
4 mM MgCl2, 5 mM N-tris(Hydroxymethyl) methyl-2-aminoethane-sulfonic 
acid, 0.25 mM CaCl2, 4 mM Na2ATP, 36 mM sucrose, and 5 mM EGTA. 
Evoked responses were stimulated with a 2-ms depolarizing pulse delivered 
via a pipette placed on the anterior ventral nerve cord. Data were acquired 
using  Pulse  software  (HEKA)  and  subsequently  analyzed  and  graphed   
using  Pulsefit  (HEKA),  Mini  Analysis  (Synaptosoft,  Inc.),  and  Igor  Pro 
(WaveMetrics).
Antibodies, immunohistochemistry, and immunoblotting
To produce the affinity-purified UNC-108 antibody KM32A-3.1, we pre-
pared a recombinant UNC-108 fragment by first transforming KG#303 
(GST–UNC-108 [1–212]) into the bacterial expression host BL21(DE3)RIL. 
We then induced expression of the protein for 17 h at 19°C from a 5-liter 
culture at an A600 of 0.4 using 30 µM IPTG and purified the GST fusion 
protein over a 5-ml glutathione-agarose column as described previously 
(Charlie et al., 2006b), except without further purification on an SDS-PAGE 
gel. Covance then produced a polyclonal antiserum in a goat via a 1,200-µg 
initial injection and two 600-µg boosts at 3-wk intervals. We affinity   
purified  UNC-108–reactive  antibodies  by  coupling  the  antigen  to  an 
AminoLink Plus column (2-ml bed volume; Thermo Fisher Scientific) accord-
ing to the manufacturer’s instructions. J. Duerr (Ohio University, Athens, 
OH) and J. Rand (Oklahoma Medical Research Foundation, Oklahoma 
City, OK) provided the UNC-17 antibody mAb1403 (as mouse mono-
clonal ascites; Duerr et al., 2001). After preadsorption of the UNC-108 anti-
body to pure GST on nitrocellulose strips, we coimmunostained wild-type 
and unc-108(ce363) adults for UNC-108 and UNC-17 using methods pre-
viously described for other antibodies (Charlie et al., 2006a,b). We used 
KM32A-3.1 at a 1:400 dilution and mAb1403 at 1:5,000.
We  produced  the  G339.3  UNC-47  antiserum  by  transforming 
KG#180  (GST–UNC-47  [1–104])  into  the  bacterial  expression  host 
BL21(DE3). We then induced expression of the protein for 17 h at 19°C 
from a 5-liter culture at an A600 of 0.4 using 30 µM IPTG and purified the 
GST fusion protein over a 5-ml glutathione-agarose column followed by an 
SDS-PAGE gel as previously described (Charlie et al., 2006b). Cocalico, 
Inc. then produced a polyclonal antiserum in a goat via a 1,200-µg initial 
injection and two 600-µg boosts at 3-wk intervals. We verified the speci-
ficity of the UNC-47 antiserum by immunostaining unc-47(gk192) (a null   
mutant), which showed no immunoreactivity at GABAergic synapses using 
the immunostaining methods and UNC-47 antiserum dilution used in this 
study. Anti-FMRFamide antiserum 671M (Marder et al., 1987) was a gift from   JCB • VOLUME 186 • NUMBER 6 • 2009   894
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Texas  red  image–registered  filter  cubes  (Semrock).  Our  illumination 
source was an X-Cite illuminator (EXFO), and we captured 12-bit images 
with a camera (ORCA-AG; Hamamatsu Photonics) controlled by Meta-
Morph Premier software (version 6.3 r1; MDS Analytical Technologies). 
To collect images, we scanned the pad using differential interference 
contrast optics for animals oriented with their ventral or dorsal surfaces 
facing the objective. We used MetaMorph to acquire a 9-plane image 
stack z series, with the planes seperated by 0.225 µm. We set Meta-
Morph  to  close  the  SmartShutter  between  different  exposures  in  the   
z series. We used 150-ms exposure times for all live animal images, which 
was well below the saturation limit of the camera chip. We recorded the 
light source power immediately after every image during imaging using 
a radiometer (model R5000; EXFO) and then used this data to linearly 
normalize fluorescence intensities when quantifying images.
To process the images, we used AutoDeblur Gold CWF (Media   
Cybernetics) to deconvolve the image stacks using the Adaptive PSF (point 
spread function) blind method and 10 iterations at the low noise setting. 
After deconvolving, we produced maximum intensity projections of each 
image stack and adjusted the scaling of wild-type and experimental images 
to match each other after linearly normalizing for any differences in light 
source power. We quantified images using MetaMorph Premier (version 
6.3 r4), again linearly normalizing the data for light source power for all 
calculations involving total integrated fluorescence intensities. To normalize 
the FMRFamide immunostaining to the UNC-47 permeabilization control, 
we divided the background-adjusted mean FMRFamide intensity per micro-
meter in the dorsal cord (using a defined region anterior to the vulva) by 
the background-adjusted mean peak intensity of the four brightest UNC-47 
synaptic vesicle clusters in the image, again linearly adjusting for any   
differences in light source power relative to the reference image.
Online supplemental material
Fig.  S1  shows  that  a  genetic  screen  ties  the  most  highly  conserved   
animal Rab protein to a synaptic signaling function. Fig. S2 shows that 
unc-108  (Rab2)  is  strongly  expressed  in  the  nervous  system.  Fig.  S3 
shows that unc-108 mutant phenotypes are not associated with permanent   
developmental defects or permanently damaged synapses. Fig. S4 shows 
a model for the physical states of Venus-tagged neuropeptides in DCVs 
before and after neuropeptide processing. Videos 1–5 show locomotion   
and  harsh  touch  response  of  wild-type  C.  elegans,  unc-108(nu415)  
mutant, egl-3(nr2090) mutant, unc-31(e928) mutant, and unc-108(nu415); 
egl-3(nr2090) double mutant, respectively. Tables S1–S3 show the worm 
strains, plasmids, and transgenic arrays used in this study, respectively. 
Online  supplemental  material  is  available  at  http://www.jcb.org/cgi/ 
content/full/jcb.200902095/DC1.
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